Share on StockTwits

CRYO-CELL International (NASDAQ:CCEL) Director George Gaines purchased 26,000 shares of the stock on the open market in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $2.00 per share, with a total value of $52,000.00. The acquisition was disclosed in a document filed with the SEC, which is available at this link.

Shares of CRYO-CELL International (NASDAQ:CCEL) traded down 0.98% on Tuesday, hitting $2.02. 450 shares of the company’s stock traded hands. CRYO-CELL International has a one year low of $1.80 and a one year high of $2.34. The stock has a 50-day moving average of $1.88 and a 200-day moving average of $1.99. The company’s market cap is $21.5 million.

Cryo-Cell International, Inc (NASDAQ:CCEL) is engaged in cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood stem cells for family use.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.